Literature DB >> 512353

HLA antigens and responses to rubella vaccination.

G C Harcourt, J M Best, J E Banatvala, L A Kennedy.   

Abstract

Attempts were made to correlate virus excretion, joint symptoms and antibody response with human leukocyte antigens (HLA) in seronegative adult women given attenuated rubella vaccine. No association was shown between HLA antigens of the A and B loci and excretion of either high or low titres of RA27/3 vaccine among 26 volunteers. However, virus excretion was influenced by such factors as the time of day at which specimens were collected and the method of virus isolation. Our study therefore failed to confirm the hypothesis that certain persons are good 'spreaders' of rubella virus and that this capacity is associated with HLA-A1 and B8. The study of joint symptoms following vaccination with Cendehill, HPV77.DE-5, RA27/3 or To-336 vaccines showed no association between such symptoms and HLA antigens. However, joint symptoms occurred within 7 days of the onset of menstruation in 33 of 47 (70%) vaccinees (P less than 0.01) and it is therefore suggested that hormonal factors must play a role. No association between HLA antigens and haemagglutination inhibition (HAI) antibody titres, 8 weeks after vaccination with RA27/3, was found amongst 34 volunteers.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 512353      PMCID: PMC2130160          DOI: 10.1017/s0022172400026231

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  17 in total

1.  HL-A antigens in congenital rubella and the role of antigens 1 and 8 in the epidemiology of natural rubella.

Authors:  M C Honeyman; D C Dorman; M A Menser; J M Forrest; J J Guinan; P Clark
Journal:  Tissue Antigens       Date:  1975-02

2.  HLA and recurrent episodic arthropathy associated with rubella vaccination.

Authors:  M M Griffiths; S L Spruance; P L Ogra; G R Thompson; C W DeWitt
Journal:  Arthritis Rheum       Date:  1977 Jul-Aug

3.  Possible associations between HLA antigens and the immune responsiveness to attenuated rubella vaccine.

Authors:  S Kato; M Kimura; I Takakura; T Sakakibara; H Inouye; K Tsuji
Journal:  Tissue Antigens       Date:  1978-05

4.  New Japanese rubella vaccine: comparative trials.

Authors:  J M Best; J E Banatvala; J M Bowen
Journal:  Br Med J       Date:  1974-07-27

5.  Interferon studies with Japanese and U.S. rubella virus strains.

Authors:  J E Potter; J E Banatvala; J M Best
Journal:  Br Med J       Date:  1973-01-27

6.  Ethnicity is a significant factor in the epidemiology of rubella and Hodgkin's disease.

Authors:  M C Honeyman; M A Menser
Journal:  Nature       Date:  1974-10-04       Impact factor: 49.962

7.  Experimental vertical transmission of rubella virus in rabbits.

Authors:  R Kono; Y Hayakawa; M Hibi; K Ishii
Journal:  Lancet       Date:  1969-02-15       Impact factor: 79.321

8.  WHO collaborative study on the sero-epidemiology of rubella in Caribbean and Middle and South American populations in 1968.

Authors:  W R Dowdle; W Ferrera; L F De Salles Gomes; D King; M Kourany; J Madalengoitia; E Pearson; W H Swanston; H C Tosi; A M Vilches
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

9.  Rubella serology by solid-phase radioimmunoassay: its potential for screening programmes.

Authors:  C Sugishita; S O'Shea; J M Best; J E Banatvala
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

10.  WHO collaborative study on the sero-epidemiology of rubella.

Authors:  W E Rawls; J L Melnick; C M Bradstreet; M Bailey; A A Ferris; N I Lehmann; F P Nagler; J Furesz; R Kono; M Ohtawara; P Halonen; J Stewart; J M Ryan; J Strauss; J Zdrazilek; J Leerhoy; H Von Magnus; R Sohier; W Ferreira
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

View more
  3 in total

Review 1.  Rubella vaccines: past, present and future.

Authors:  J M Best
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

2.  Rubella-specific immune complexes after congenital infection and vaccination.

Authors:  P K Coyle; J S Wolinsky; E Buimovici-Klein; R Moucha; L Z Cooper
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

3.  HLA genotypes and rubella vaccine immune response: additional evidence.

Authors:  Inna G Ovsyannikova; V Shane Pankratz; Beth R Larrabee; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2014-05-15       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.